Replies to post #362965 on Innovation Pharmaceuticals Inc (IPIX)

[govorchin]

Weren’t we supposed to get results from Russian Tess pus northwestern ?

[Lemoncat]

If great COVID results indicating a new SOC: $3-6/share.

If ok COVID results and some good non-COVID preclinical data this summer: $1-2/share

If COVID trial fails: $300-400M or $0.75-$1

Don't know where $15B or $35/share is going to come from. We know the market valued everything in the pipeline at around $20M in late 2019 so most valuation is coming from COVID.

Go IPIX!